Epidemiology, causes, and treatment of epilepsy in sub-Saharan Africa

The Lancet Neurology

Volumn 13, Issue 10, 2014, Pages 1029-1044

  Ba Diop, Awa ^a   Marin, Benoît ^a,b   Druet Cabanac, Michel ^a   Ngoungou, Edgard B ^a,c   Newton, Charles R ^d,e   Preux, Pierre Marie ^a,b  

^a UNIVERSITÉ DE LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DES SCIENCES DE LA SANTÉ   (Gabon)

^d Geographic Medicine Research Coast   (Kenya)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA SOUTH OF THE SAHARA; ASIA; BIRTH INJURY; CENTRAL NERVOUS SYSTEM INFECTION; EPILEPSY; EUROPE; HEALTH CARE ACCESS; HUMAN; NORTH AMERICA; PREVALENCE; REVIEW; RISK FACTOR; TRAUMATIC BRAIN INJURY; TROPICS; AGE DISTRIBUTION; BRAIN INJURY; CENTRAL NERVOUS SYSTEM INFECTIONS; COMPLICATION; DRUG UTILIZATION; EPIDEMIOLOGY; GENETICS; INCIDENCE; MALNUTRITION; PATHOPHYSIOLOGY; SEIZURE; SEIZURES, FEBRILE; SEX RATIO; SOCIOECONOMICS;

ANTICONVULSIVE AGENT;

AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; ANTICONVULSANTS; BIRTH INJURIES; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM INFECTIONS; DRUG UTILIZATION; EPILEPSY; HUMANS; INCIDENCE; MALNUTRITION; PREVALENCE; RISK FACTORS; SEIZURES; SEIZURES, FEBRILE; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS;

EID: 84907966331     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70114-0     Document Type: Review

References (162)

1. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005, 46:470-472.
2. Guidelines for Epidemiologic Studies on Epilepsy. Epilepsia 1993, 34:592-596. Commission on Epidemiology and Prognosis, International League Against EpilepsyInternational League Against Epilepsy.
3. Preux P-M, Druet-Cabanac M Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 2005, 4:21-31.
4. Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010, 51:883-890.
5. Mushi D, Hunter E, Mtuya C, Mshana G, Aris E, Walker R Social-cultural aspects of epilepsy in Kilimanjaro Region, Tanzania: Knowledge and experience among patients and carers. Epilepsy Behav 2011, 20:338-343.
6. Viteva E Impact of stigma on the quality of life of patients with refractory epilepsy. Seizure 2013, 22:64-69.
7. Burton K, Rogathe J, Hunter E, et al. Behavioural comorbidity in Tanzanian children with epilepsy: a community-based case-control study. Dev Med Child Neurol 2011, 53:1135-1142.
8. Kariuki SM, Ikumi M, Ojal J, et al. Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast. Brain 2011, 134:1519-1528.
9. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
10. Murray CJL, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
11. Salomon JA, Vos T, Hogan DR, et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380:2129-2143.
12. Burton K, Rogathe J, Whittaker RG, et al. Co-morbidity of epilepsy in Tanzanian children: a community-based case-control study. Seizure J Br Epilepsy Assoc 2012, 21:169-174.
13. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
14. Yemadje L-P, Houinato D, Quet F, Druet-Cabanac M, Preux P-M Understanding the differences in prevalence of epilepsy in tropical regions. Epilepsia 2011, 52:1376-1381.
15. Ngugi AK, Bottomley C, Kleinschmidt I, et al. Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. Lancet Neurol 2013, 12:253-263.
16. Kaiser C, Pion SDS, Boussinesq M Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis 2013, 7:e2147.
17. Winkler AS Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health 2012, 106:261-274.
18. Quattrocchi G, Nicoletti A, Marin B, Bruno E, Druet-Cabanac M, Preux P-M Toxocariasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis 2012, 6:e1775.
19. Mitchell KB, Kornfeld J, Adiama J, et al. Nodding syndrome in northern Uganda: overview and community perspectives. Epilepsy Behav EB 2013, 26:22-24.
20. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011, 77:1005-1012.
21. Tekle-Haimanot R, Forsgren L, Ekstedt J Incidence of epilepsy in rural central Ethiopia. Epilepsia 1997, 38:541-546.
22. Houinato D, Yemadje L-P, Glitho G, et al. Epidemiology of epilepsy in rural Benin: prevalence, incidence, mortality, and follow-up. Epilepsia 2013, 54:757-763.
23. Rwiza HT, Kilonzo GP, Haule J, et al. Prevalence and incidence of epilepsy in Ulanga, a rural Tanzanian district: a community-based study. Epilepsia 1992, 33:1051-1056.
24. Winkler AS, Kerschbaumsteiner K, Stelzhammer B, Meindl M, Kaaya J, Schmutzhard E Prevalence, incidence, and clinical characteristics of epilepsy-a community-based door-to-door study in northern Tanzania. Epilepsia 2009, 50:2310-2313.
25. Debouverie M, Kaboré J, Dumas M, Giordano C, Gentilini M, Chieze F Epidemiology of epilepsy in Burkina Faso. Neurol Trop 1993, 57-61.
26. Kaiser C, Asaba G, Leichsenring M, Kabagambe G High incidence of epilepsy related to onchocerciasis in West Uganda. Epilepsy Res 1998, 30:247-251.
27. Mung'ala-Odera V, White S, Meehan R, et al. Prevalence, incidence and risk factors of epilepsy in older children in rural Kenya. Seizure 2008, 17:396-404.
28. Ngugi AK, Bottomley C, Scott JAG, et al. Incidence of convulsive epilepsy in a rural area in Kenya. Epilepsia 2013, 54:1352-1359.
29. Snow RW, Williams REM, Rogers JE, Mung'ala VO, Peshu N The prevalence of epilepsy among a rural Kenyan population: its association with premature mortality. Trop Geogr Med 1994, 46:175-179.
30. Coleman R, Loppy L, Walraven G The treatment gap and primary health care for people with epilepsy in rural Gambia. Bull World Health Organ 2002, 80:378-383.
31. Osuntokun BO, Adeuja AO, Nottidge VA, et al. Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia 1987, 28:272-279.
32. Longe AC, Osuntokun BO Prevalence of neurological disorders in Udo, a rural community in southern Nigeria. Trop Geogr Med 1989, 41:36-40.
33. Simms V, Atijosan O, Kuper H, Nuhu A, Rischewski D, Lavy C Prevalence of epilepsy in Rwanda: A national cross-sectional survey. Trop Med Int Health 2008, 13:1047-1053.
34. Christianson AL, Zwane ME, Manga P, Rosen E, Venter A, Kromberg JG Epilepsy in rural South African children-prevalence, associated disability and management. South Afr Med J Suid-Afr Tydskr Vir Geneeskd 2000, 90:262-266.
35. Dent W, Helbok R, Matuja WBP, Scheunemann S, Schmutzhard E Prevalence of active epilepsy in a rural area in south Tanzania: a door-to-door survey. Epilepsia 2005, 46:1963-1969.
36. Kouassi B, Koffi J, Diarra J, et al. Prévalence de l'épilepsie en milieu rural ivoirien: étude pilote. Pub Méd Afr 1988, 89:25-30.
37. Avode Dossou G, Houinato D, Tevoedjre M, Adjien C, Adoukonou T, Guedou F Epilepsy in schools in Cotonou (Benin). Epilepsie en Milieu Scolaire a Cotonou (Benin) (English). Afr J Neurol Sci 2003, 22. 10.4314/ajns.v22i2.7539.
38. Yemadje L-P, Houinato D, Boumédiène F, Ngoungou EB, Preux P-M, Druet-Cabanac M Prevalence of epilepsy in the 15 years and older in Benin: a door-to-door nationwide survey. Epilepsy Res 2012, 99:318-326.
39. Ndiaye IP, Mauferon JB, Diagne M. Épidémiologie de l'épilepsie au Sénégal. Communication presented to the 7th Congress of the Pan-African Association of Neurological Sciences, Abidjan, CÔte d'Ivoire. April 23-30, 1986.
40. Houinato D, Tibarbache H, Houeze F, et al. L'épilepsie en milieu professionnel urbain au Sud-Bénin. Arch Mal Prof Environ 2007, 68:244-250.
41. Birbeck GL, Kalichi EMN Epilepsy prevalence in rural Zambia: a door-to-door survey. Trop Med Int Health 2004, 9:92-95.
42. Kaiser C, Kipp W, Asaba G, et al. The prevalence of epilepsy follows the distribution of onchocerciasis in a west Ugandan focus. Bull World Health Organ 1996, 74:361-367.
43. Farnarier G, Diop S, Coulibaly B, et al. Onchocerciasis and epilepsy: epidemiological survey in Mali. Méd Trop Rev Corps Santé Colon 2000, 60:151-155.
44. Ndoye NF, Sow AD, Diop AG, et al. Prevalence of epilepsy its treatment gap and knowledge, attitude and practice of its population in sub-urban Senegal an ILAE/IBE/WHO study. Seizure J Br Epilepsy Assoc 2005, 14:106-111.
45. Balogou AAK, Grunitzky EK, Belo M, et al. Management of epilepsy patients in Batamariba district, Togo. Acta Neurol Scand 2007, 116:211-216.
46. Debrock C, Preux PM, Houinato D, et al. Estimation of the prevalence of epilepsy in the Benin region of Zinvié using the capture-recapture method. Int J Epidemiol 2000, 29:330-335.
47. Dumas M, Grunitzky E, Deniau M, et al. Epidemiological study of neuro-cysticercosis in northern Togo (West Africa). Acta Leiden 1989, 57:191-196.
48. Kaamugisha J, Feksi AT Determining the prevalence of epilepsy in the semi-urban population of Nakuru, Kenya, comparing two independent methods not apparently used before in epilepsy studies. Neuroepidemiology 1988, 7:115-121.
49. Balogou AA, Grunitzky KE, Beketi KA, Bouteille B, Dumas M Cysticercosis and epilepsy in the city of Tone, north of Togo. Rev Neurol (Paris) 2000, 156:270-273.
50. Andriantseheno L, Ralaizandriny D Prévalence communautaire de l'épilepsie chez les Malgaches. Epilepsies Montrouge 2004, 16:83-86.
51. Goudsmit J, van der Waals FW, Gajdusek C Epilepsy in the Gbawein and Wroughbarh Clan of Grand Bassa County, Liberia: the endemic occurrence of "See-ee" in the native population. Neuroepidemiology 1983, 2:24-34.
52. Almu S, Tadesse Z, Cooper P, Hackett R The prevalence of epilepsy in the Zay Society, Ethiopia-an area of high prevalence. Seizure 2006, 15:211-213.
53. Houinato D, Adjien K, Gnonlonfon D, Adoukonou T, Dema F, Avode D Etude de la prévalence de l'épilepsie á Dangbo dans le département de l'Oueme au Benin. Benin Méd 2007, 37:14-17.
54. Njamnshi A, Sini V, Djientcheu V, et al. Risk factors associated with epilepsy in a rural area in Cameroon: a preliminary study. Afr J Neurol Sci 2007, 26:18-26.
55. Osuntokun BO, Schoenberg BS, Nottidge VA, et al. research protocol for measuring the prevalence of neurologic disorders in developing countries. Neuroepidemiology 1982, 1:143-153.
56. Nitiéma P, Carabin H, Hounton S, et al. Prevalence case-control study of epilepsy in three Burkina Faso villages. Acta Neurol Scand 2012, 126:270-278.
57. Dongmo L, Ndo D, Atchou G, Njamnshi A Epilepsie au Sud-Cameroun: enquête préliminaire dans le village Bilomo. Bull Soc Pethol Exot 2000, 93:266-267.
58. Kaudjhis P. Les agrégats de l'épilepsie de M'brou: approche électroclinique et étiologique. Medical Thesis. Abidjan, CÔte-d'Ivoire, 1995.
59. Nkwi PN, Ndonko FT The epileptic among the Bamileke of Maham in the Nde Division, West Province of Cameroon. Cult Med Psychiatry 1989, 13:437-448.
60. Kouadjo Y. Génétique et épilepsie: à propos d'un foyer d'épilepsie observé dans un village ivoirien. Medical Thesis. Abidjan, CÔte-d'Ivoire, 1990.
61. Prischich F, De Rinaldis M, Bruno F, et al. High prevalence of epilepsy in a village in the Littoral Province of Cameroon. Epilepsy Res 2008, 82:200-210.
62. Edwards T, Scott AG, Munyoki G, et al. Active convulsive epilepsy in a rural district of Kenya: a study of prevalence and possible risk factors. Lancet Neurol 2008, 7:50-56.
63. Burton KJ, Rogathe J, Whittaker R, et al. Epilepsy in Tanzanian children: association with perinatal events and other risk factors. Epilepsia 2012, 53:752-760.
64. Hunter E, Rogathi J, Chigudu S, et al. Prevalence of active epilepsy in rural Tanzania: a large community-based survey in an adult population. Seizure J Br Epilepsy Assoc 2012, 21:691-698.
65. Duggan MB Epilepsy in rural Ugandan children: seizure pattern, age of onset and associated findings. Afr Health Sci 2010, 10:218.
66. Paul A, Adeloye D, George-Carey R, Kolčić I, Grant L, Chan KY An estimate of the prevalence of epilepsy in Sub-Saharan Africa: a systematic analysis. J Glob Health 2012, 2:020405.
67. Newton CR, Garcia HH Epilepsy in poor regions of the world. Lancet 2012, 380:1193-1201.
68. Placencia M, Sander JW, Shorvon SD, Ellison RH, Cascante SM Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain J Neurol 1992, 115:783-794.
69. Preux P, Druet-Cabanac M, Debrock C, Tapie P, Dumas M Questionnaire d'investigation de l'épilepsie dans les pays tropicaux. Bull Soc Pathol Exot 2000, 93:276-278. the Comité de Recherche sur l'Epilepsie de l'Institut d'Epidémiologie Neurologique et de Neurologie Tropicale de Limoges.
70. Higgins JPT, Thompson SG, Deeks JJ, Altman DG Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
71. Forsgren L Epidemiology and prognosis of epilepsy and its treatment. The treatment of epilepsy 2004, 21-42. Blackwell Science Oxford, Malden. S. Shorvon, E. Perucca, D. Fish, E. Dodson (Eds.).
72. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA Epilepsy and mortality in Africa: a review of the literature. Epilepsia 2005, 46(suppl 11):33-35.
73. Kaiser C, Asaba G, Kasoro S, Rubaale T, Kabagambe G, Mbabazi M Mortality from epilepsy in an onchocerciasis-endemic area in West Uganda. Trans R Soc Trop Med Hyg 2007, 101:48-55.
74. Ngugi AK. Prevalence, incidence and mortality of epilepsy in four health and demographic surveillance sites in sub-Saharan Africa. PhD thesis. London School of Hygiene and Tropical Medicine (University of London), 2012.
75. La prévention primaire des troubles mentaux, neurologiques et psychosociaux 1999, WHO, WHO, Geneva.
76. Kamgno J, Pion SDS, Boussinesq M Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia 2003, 44:956-963.
77. Munyoki G, Edwards T, White S, et al. Clinical and neurophysiologic features of active convulsive epilepsy in rural Kenya: A population-based study. Epilepsia 2010, 51:2370-2376.
78. Diagana M, Nsengiyumva G, Tuillas M, et al. Electroencephalograms (EEG) in 250 patients with epilepsy in a cysticercosis endemic area in Burundi. Neurophysiol Clin 2005, 35:1-10.
79. Nicoletti A, Bartoloni A, Sofia V, et al. Epilepsy and toxocariasis: a case-control study in Burundi. Epilepsia 2007, 48:894-899.
80. Dongmo L, Druet-Cabanac M, Moyou SR, et al. Cysticercosis and epilepsy: a case-control study in Mbam Valley, Cameroon. Bull Société Pathol Exo 2004, 97:105-108.
81. Petitjeans F, Gandin C, Sturtz F, Fila A, Chazot G, Vandenberghe A Epilepsie dans les pays en voie de développement: recensement et description de cas dans deux villages congolais. Epilepsies 1995, 7:167-178.
82. Tekle-Haimanot R, Forsgren L, Abebe M, et al. Clinical and electroencephalographic characteristics of epilepsy in rural Ethiopia: a community-based study. Epilepsy Res 1990, 7:230-239.
83. Feksi AT, Kaamugisha J, Gatiti S, Sander JWAS, Shorvon SD A comprehensive community epilepsy programme: The Nakuru project. Epilepsy Res 1991, 8:252-259.
84. Druet-Cabanac M, Preux PM, Bouteille B, et al. Onchocerciasis and epilepsy: a matched case-control study in the Central African Republic. Am J Epidemiol 1999, 149:565-570.
85. Kaiser C, Benninger C, Asaba G, et al. Clinical and electro-clinical classification of epileptic seizure in west Uganda. Bull Société Pathol Exot 1990, 93:255-259.
86. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B, Bouteille B, Nsizabira L, Preux P-M Cysticercosis as a major risk factor for epilepsy in Burundi, east Africa. Epilepsia 2003, 44:950-955.
87. Kaiser C, Rubaale T, Tukesiga E, et al. Association between onchocerciasis and epilepsy in the Itwara hyperendemic focus, West Uganda: Controlling for time and intensity of exposure. Am J Trop Med Hyg 2011, 85:225-228.
88. Matuja WB, Kilonzo G, Mbena P, et al. Risk factors for epilepsy in a rural area in Tanzania. A community-based case-control study. Neuroepidemiology 2001, 20:242-247.
89. Carter JA, Neville BGR, White S, et al. Increased prevalence of epilepsy associated with severe falciparum malaria in children. Epilepsia 2004, 45:978-981.
90. Ngoungou EB, Dulac O, Poudiougou B, et al. Epilepsy as a consequence of cerebral malaria in area in which malaria is endemic in Mali, West Africa. Epilepsia 2006, 47:873-879.
91. Ngoungou EB, Koko J, Druet-Cabanac M, et al. Cerebral malaria and sequelar epilepsy: first matched case-control study in Gabon. Epilepsia 2006, 47:2147-2153.
92. Ottman R, Lee JH, Hauser WA, Risch N Birth cohort and familial risk of epilepsy: the effect of diminished recall in studies of lifetime prevalence. Am J Epidemiol 1995, 141:235-241.
93. Global campaign against epilepsy: out of the shadows. Geneva WHO, (accessed July 19, 2014). http://www.who.int/mental_health/management/globalepilepsycampaign/en/.
94. Lennox WG The heredity of epilepsy as told by relatives and twins. JAMA 1951, 146:529-536.
95. Diop AG, de Boer HM, Mandlhate C, Prilipko L, Meinardi H The global campaign against epilepsy in Africa. Acta Trop 2003, 87:149-159.
96. Ogunniyi A, Osuntokun BO, Bademosi O, Adeuja AO, Schoenberg BS Risk factors for epilepsy: case-control study in Nigerians. Epilepsia 1987, 28:280-285.
97. Matuja WB Aetiological factors in Tanzanian epileptics. East Afr Med J 1989, 66:343-348.
98. Crepin S, Houinato D, Nawana B, Avode GD, Preux P-M, Desport J-C Link between epilepsy and malnutrition in a rural area of Benin. Epilepsia 2007, 48:1926-1933.
99. Rothenberg G, Schubert S Assessment of late complications of malaria in travelers to the tropics. Z Für Gesamte Inn Med Ihre Grenzgeb 1983, 38:46-47.
100. Dada TO Parasites and epilepsy in Nigeria. Trop Geogr Med 1970, 22:313-322.
101. Cruz M, Schantz P, Cruz I, et al. Epilepsy and neurocysticercosis in an Andean community. Int J Epidemiol 1999, 28:799-803.
102. Medina MT, Dubon-Murcia SA, Aguilar-Estrada RL, Chaves-Sell F, Bu J Neurocysticercosis and epilepsy. Epilepsies 2010, 22:126-133.
103. Nicoletti A, Bartoloni A, Reggio A, et al. Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. Neurology 2002, 58:1256-1261.
104. Quet F, Guerchet M, Pion SDS, Ngoungou EB, Nicoletti A, Preux P-M Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia 2010, 51:830-837.
105. Ibrahim N, Azman R, Basri H, Phadke P Neurocysticercosis in a Malaysian muslim. Neurol J Southeast Asia 2003, 8:45-48.
106. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E Anticysticercal and antitoxocaral antibodies in people with epilepsy in rural Tanzania. Trans R Soc Trop Med Hyg 2008, 102:1032-1038.
107. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E Epilepsy and neurocysticercosis in rural Tanzania-An imaging study. Epilepsia 2009, 50:987-993.
108. Blocher J, Schmutzhard E, Wilkins PP, et al. A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approaches. PLoS Negl Trop Dis 2011, 5:e1185.
109. Kanobana K, Praet N, Kabwe C, et al. High prevalence of Taenia solium cysticerosis in a village community of Bas-Congo, Democratic Republic of Congo. Int J Parasitol 2011, 41:1015-1018.
110. Kipp W, Kasoro S, Burnham G Onchocerciasis and epilepsy in Uganda. Lancet 1994, 343:183-184.
111. Pion SDS, Kalser C, Boutros-Toni F, et al. Epilepsy in onchocerciasis endemic areas: Systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis 2009, 3:e461.
112. Boussinesq M, Pion SDS, Demanga-Ngangue, Kamgno J Relationship between onchocerciasis and epilepsy: a matched case-control study in the Mbam Valley, Republic of Cameroon. Trans R Soc Trop Med Hyg 2002, 96:537-541.
113. Pion SDS, Boussinesq M Significant association between epilepsy and presence of onchocercal nodules: case-control study in Cameroon. Am J Trop Med Hyg 2012, 86:557.
114. Preux P-M, Marin B, Druet-Cabanac M, Farnarier G Onchocercose et épilepsie. Epilepsies 2010, 22:116-119.
115. Kabore JK, Cabore JW, Melaku Z, Druet-Cabanac M, Preux PM Epilepsy in a focus of onchocerciasis in Burkina Faso. Lancet 1996, 347:836.
116. König R, Nassri A, Meindl M, et al. The role of Onchocerca volvulus in the development of epilepsy in a rural area of Tanzania. Parasitology 2010, 137:1559-1568.
117. Druet-Cabanac M, Boussinesq M, Dongmo L, Farnarier G, Bouteille B, Preux PM Review of epidemiological studies searching for a relationship between onchocerciasis and epilepsy. Neuroepidemiology 2004, 23:144-149.
118. Dozie INS, Onwuliri COE, Nwoke BEB, et al. Onchocerciasis and epilepsy in parts of the Imo river basin, Nigeria: a preliminary report. Public Health 2006, 120:448-450.
119. Reik L, Abubakar A, Opoka M, et al. Nodding Syndrome-South Sudan, 2011. Cent Dis Control Prev CDC 2012, 61:52-54.
120. Donnelly J CDC planning trial for mysterious nodding syndrome. Lancet 2012, 379:299.
121. Winkler AS, Friedrich K, Meindl M, et al. Clinical characteristics of people with head nodding in southern Tanzania. Trop Doct 2010, 40:173-175.
122. Sejvar JJ, Kakooza AM, Foltz JL, et al. Clinical, neurological, and electrophysiological features of nodding syndrome in Kitgum, Uganda: an observational case series. Lancet Neurol 2013, 12:166-174.
123. Dowell SF, Sejvar JJ, Riek L, et al. Nodding Syndrome. Emerg Infect Dis 2013, 19:1374. 73.
124. Winkler AS, Friedrich K, König R, et al. The head nodding syndrome-clinical classification and possible causes. Epilepsia 2008, 49:2008-2015.
125. Spencer PS, Vandemaele K, Richer M, et al. Nodding syndrome in Mundri county, South Sudan: Environmental, nutritional and infectious factors. Afr Health Sci 2013, 13:183-204.
126. Mitchell KB, Kornfeld J, Adiama J, et al. Nodding syndrome in northern Uganda: overview and community perspectives. Epilepsy Behav 2013, 26:22-24.
127. Idro R, Opoka RO, Aanyu HT, et al. Nodding syndrome in Ugandan children-clinical features, brain imaging and complications: a case series. BMJ Open 2013, 3:e002540.
128. Tumwine J, Vandemaele K, Chungong S, et al. Clinical and epidemiologic characteristics of nodding syndrome in Mundri County, southern Sudan. Afr Health Sci 2012, 12:242-248.
129. Foltz JL, Makumbi I, Sejvar JJ, et al. An epidemiologic investigation of potential risk factors for nodding syndrome in Kitgum District, Uganda. PloS One 2013, 8:e66419.
130. Ngoungou EB, Niare-Doumbo S, Preux P-M, Doumbo O Paludisme et épilepsie en zone tropicale. Epilepsies 2010, 22:111-115.
131. Ngoungou EB, Preux P-M Cerebral malaria and epilepsy. Epilepsia 2008, 49(suppl 6):19-24.
132. Postels DG, Taylor TE, Molyneux M, et al. Neurologic outcomes in retinopathy-negative cerebral malaria survivors. Neurology 2012, 79:1268-1272.
133. Birbeck GL, Molyneux ME, Kaplan PW, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010, 9:1173-1181.
134. Birbeck GL, Beare N, Lewallen S, et al. Identification of malaria retinopathy improves the specificity of the clinical diagnosis of cerebral malaria: findings from a prospective cohort study. Am J Trop Med Hyg 2010, 82:231-234.
135. Akyol A, Bicerol B, Ertug S, Ertabaklar H, Kiylioglu N Epilepsy and seropositivity rates of Toxocara canis and Toxoplasma gondii. Seizure 2007, 16:233-237.
136. Silberberg D, Katabira E Neurological Disorders. Disease and Mortality in Sub-Saharan Africa 2006, World Bank, Washington DC, (accessed Nov 9, 2013). http://www.ncbi.nlm.nih.gov/books/NBK2295/, 2nd edn. D.T. Jamison, R.G. Feachem, M.W. Makgoba (Eds.).
137. Sander JW, Shorvon SD Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996, 61:433-443.
138. Silverman IE RL Poststroke seizures. Arch Neurol 2002, 59:195-201.
139. Howitt SC, Jones MP, Jusabani A, et al. A cross-sectional study of quality of life in incident stroke survivors in rural northern Tanzania. J Neurol 2011, 258:1422-1430.
140. Walker R, Whiting D, Unwin N, et al. Stroke incidence in rural and urban Tanzania: a prospective, community-based study. Lancet Neurol 2010, 9:786-792.
141. Sagui E Les accidents vasculaires cerebraux en Afrique subsaharienne. Médecine Trop 2007, 67:596-600.
142. De Toffol B Epilepsies: étiologie, diagnostic, évolution, pronostic, traitement. Rev Prat 1995, 45:885-891.
143. Mbuba CK, Ngugi AK, Fegan G, et al. Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study. Lancet Neurol 2012, 11:688-696.
144. Diop A, Ndiaye M, Diagne M, et al. Filières des soins anti-épileptiques en Afrique. Epilepsies 1998, 10:115-121.
145. Adamolekun B, Meinardi H Problems of drug therapy of epilepsy in developing countries. Trop Geogr Med 1990, 42:178-181.
146. Kaiser C, Asaba G, Mugisa C, et al. Antiepileptic drug treatment in rural Africa: involving the community. Trop Doct 1998, 28:73-77.
147. Mbuba CK, Ngugi AK, Newton CR, Carter JA The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia 2008, 49:1491-1503.
148. Meyer A-CL, Dua T, Boscardin WJ, Escarce JJ, Saxena S, Birbeck GL Critical determinants of the epilepsy treatment gap: a cross-national analysis in resource-limited settings. Epilepsia 2012, 53:2178-2185.
149. Meyer A-C, Dua T, Ma J, Saxena S, Birbeck G Global disparities in the epilepsy treatment gap: a systematic review. Bull World Health Organ 2010, 88:260-266.
150. WHO Mental Health Gap Action Programme (mhGAP) WHO, (accessed Nov 8, 2013). http://www.who.int/mental_health/mhgap/en/.
151. Meinardi H, Scott RA, Reis R, Sander JW The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001, 42:136-149.
152. Ratsimbazafy V, Andrianabelina R, Randrianarisona S, Preux P-M, Odermatt P Treatment gap for people living with epilepsy in Madagascar. Trop Doct 2011, 41:38-39.
153. Ilangaratne NB, Mannakkara NN, Bell GS, Sander JW Phenobarbital: missing in action. Bull World Health Organ 2012, 90:871. 71A.
154. Bruno E, Nimaga K, Foba I, et al. Results of an Action-Research on Epilepsy in Rural Mali. PLoS One 2012, 7:e44469.
155. Chomba EN, Haworth A, Mbewe E, et al. The Current Availability of Antiepileptic Drugs in Zambia: Implications for the ILAE/WHO "Out of the Shadows" Campaign. Am J Trop Med Hyg 2010, 83:571-574.
156. Cameron A, Bansal A, Dua T, et al. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia 2012, 53:962-969.
157. Boling W, Palade A, Wabulya A, et al. Surgery for pharmacoresistant epilepsy in the developing world: A pilot study. Epilepsia 2009, 50:1256-1261.
158. Tran DS, Ngoungou EB, Quet F, Preux PM Prise en charge de l'épilepsie dans les pays en développement. Med Trop (Mars) 2007, 67:635-643.
159. Thurman DJ, Beghi E, Begley CE, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011, 52(suppl 7):2-26.
160. Osungbade KO, Siyanbade SL Myths, misconceptions, and misunderstandings about epilepsy in a Nigerian rural community: implications for community health interventions. Epilepsy Behav 2011, 21:425-429.
161. Rafael F, Houinato D, Nubukpo P, et al. Sociocultural and psychological features of perceived stigma reported by people with epilepsy in Benin. Epilepsia 2010, 51:1061-1068.
162. Rwiza HT, Matuja WB, Kilonzo GP, et al. Knowledge, attitude, and practice toward epilepsy among rural Tanzanian residents. Epilepsia 1993, 34:1017-1023.